Table 1.
ICOSS-2 characteristics of respondents who received two doses of mRNA vaccines split by habitual nighttime sleep duration.
| Habitual nighttime sleep duration | Generalized LM | Chi2-test | ||||
|---|---|---|---|---|---|---|
| Characteristic | <6 h | 6–9 h | >9 h | df; Wald Chi2 | df; Pearson Chi2 | P value |
| Responders, n (%) | 990 (16.7) | 4733 (80.0) | 195 (3.3) | -- | -- | -- |
| Age, mean (SD) | 46.4 (16.3) | 45.2 (17.6) | 42.1 (17.8) | 2; 11.251 | -- | 0.004 |
| Female, n (%) | 615 (62.1) | 2964 (62.6) | 145 (74.4) | -- | 2; 11.386 | 0.003 |
| Ethnicity, n (%) | -- | 4; 70.966 | <0.001 | |||
| Caucasian/White | 456 (46.1) | 2323 (49.1) | 148 (75.9) | |||
| Asian | 433 (43.7) | 2061 (43.5) | 32 (16.4) | |||
| other | 101 (10.2) | 349 (7.4) | 15 (7.7) | |||
| Smoking status, n (%) | -- | 6; 29.326 | <0.001 | |||
| never or less than once per month | 760 (76.8) | 3832 (81.0) | 136 (69.7) | |||
| less than once per week | 25 (2.5) | 119 (2.5) | 8 (4.1) | |||
| 1–5 days per week | 23 (2.3) | 126 (2.7) | 4 (2.1) | |||
| every day or almost daily | 182 (18.4) | 656(13.9) | 47 (24.1) | |||
| Weekly alcohol consumption, n (%) | -- | 4; 29.079 | <0.001 | |||
| not at all | 410 (41.4) | 1624 (34.3) | 56 (28.7) | |||
| moderate | 540 (54.5) | 2975 (62.9) | 134 (68.7) | |||
| excessive | 40 (4.0) | 134 (2.8) | 5 (2.6) | |||
| Weekly PAL score, mean (SD) | 1.6 (2.2) | 1.9 (2.3) | 2.0 (2.2) | 2; 8.831 | -- | 0.012 |
| Marital status, n (%) | 4; 24.091 | <0.001 | ||||
| single | 291 (29.4) | 1456 (30.8) | 59 (30.3) | |||
| married /in relationship | 572 (57.8) | 2894 (61.1) | 123 (63.1) | |||
| divorced or separated/widowed | 127 (12.8) | 383 (8.1) | 13 (6.7) | |||
| Living area, n (%) | -- | 2; 11.150 | 0.004 | |||
| urban | 548 (55.4) | 2688 (56.8) | 133 (68.2) | -- | ||
| BMI ≥ 30 kg/m2, n (%) | 170 (17.2) | 563 (11.9) | 30 (15.4) | -- | 2; 21.412 | <0.001 |
| University, College or above, n (%) | 553 (55.9) | 3107 (65.6) | 124 (63.6) | -- | 2; 34.023 | <0.001 |
| Test-positive for SARS-CoV-2, n (%) | 112 (11.3) | 405 (8.6) | 21 (10.8) | -- | 2; 8.213 | 0.016 |
| Presence of | ||||||
| diseases of the circulatory system, n (%) | 250 (25.3) | 938 (19.8) | 53 (27.2) | -- | 2; 19.281 | <0.001 |
| diabetes mellitus, n (%) | 216 (21.8) | 689 (14.6) | 35 (17.9) | -- | 2; 32.950 | <0.001 |
| diseases of respiratory system, n (%) | 120 (12.1) | 423 (8.9) | 34 (17.4) | -- | 2; 22.970 | <0.001 |
| neuropsychiatric disorders, n (%) | 425 (42.9) | 1579 (33.4) | 125 (64.1) | -- | 2; 101.803 | <0.001 |
| other diseases, n (%) | 457 (46.2) | 1887 (39.9) | 121 (62.1) | -- | 2; 47.864 | <0.001 |
| hypertension, n (%) | 198 (20.0) | 752 (15.9) | 43 (22.1) | -- | 2; 13.925 | <0.001 |
Group comparisons were performed by Chi-Square testing for categorical variables and generalized linear models for continuous variables.
df degree of freedom, LM linear model, PAL physical activity level.